A 4.98-hectare site (49,767 m²) with 47,518 m² of total floor area · CNY 490 million invested.
Site and floor areas from public project filings; staff and quality-team figures as of 2025.
N-Acetylcysteine is manufactured at the production site of Zhejiang Hichi Pharmaceutical (NEEQ: 834402), controlled by Beijing Beilu Pharmaceutical (Shenzhen ChiNext: 300016). The site runs dedicated API workshops with independent quality-control laboratories.
| Inspection | Five-day on-site GMP inspection, 13-18 July 2025 |
| Outcome | Closed with zero deficiencies |
| Certificate | ANVISA GMP No. 0137263/24-4 · scope: iohexol |
| Decision date | 1 September 2025 |
Source: announcement 2025-023 of Zhejiang Hichi Pharmaceutical (NEEQ: 834402) and announcement 2025-097 of Beijing Beilu Pharmaceutical (300016), both dated 2 September 2025. Certificate holder: Zhejiang Hichi Pharmaceutical Co., Ltd. – our manufacturing base.
Workshops, reactors, utility systems and quality-control laboratories at the manufacturing site.
Tell us grade, pharmacopoeia, quantity and destination. We reply with COA sample, MSDS and a price proposal.
